“Secukinumab Is Associated With Improvements in Real-World Effectiveness Outcomes Through 12 Months of Follow-Up in Patients With Plaque Psoriasis: Analysis of US Dermatology Electronic Medical Records”. SKIN The Journal of Cutaneous Medicine 3, no. 2 (March 11, 2019): 173. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/530.